,Set,NGenes,Direction,PValue,FDR
1,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,25,Down,7.525664213066e-06,0.00618609598314025
2,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,17,Down,1.94698206605351e-05,0.00800209629147991
3,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,13,Down,0.000288721354967296,0.0601684129388473
4,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,14,Down,0.000292790330602663,0.0601684129388473
5,WP_VITAMIN_B12_METABOLISM,25,Down,0.00047150608557835,0.0775156004690808
6,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,28,Down,0.000847035750713627,0.106863782488053
7,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,8,Down,0.000910032210968824,0.106863782488053
8,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,41,Down,0.00105264618066767,0.108159395063603
9,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,35,Down,0.00120610155035909,0.110157274932797
10,WP_GPCRS_OTHER,13,Down,0.00195028662518239,0.157417501681499
11,WP_POSTCOVID_NEUROINFLAMMATION,13,Down,0.00210656024147991,0.157417501681499
12,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,5,Up,0.00246932833393919,0.169148990874834
13,WP_IL26_SIGNALING,32,Down,0.00307367904000576,0.194351090068056
14,WP_PROSTAGLANDIN_SIGNALING,23,Down,0.00346776890787976,0.201184415483718
15,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,12,Down,0.00367124845773208,0.201184415483718
16,WP_BURN_WOUND_HEALING,62,Down,0.00410324641425081,0.210804284532136
17,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.00476263318942061,0.219973061544212
18,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.00481692835498274,0.219973061544212
19,WP_FOLATE_METABOLISM,38,Down,0.00532650789348294,0.229995525579324
20,WP_ASPIRIN_AND_MIRNAS,8,Down,0.00581365742046474,0.229995525579324
21,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.00587579809874185,0.229995525579324
22,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,15,Down,0.00729822681927309,0.264735030728008
23,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,10,Down,0.00740742786708537,0.264735030728008
24,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,2,Down,0.00787843829676401,0.269836511664167
25,WP_SPINAL_CORD_INJURY,69,Down,0.00859938302972616,0.276700547029005
26,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.00875208542914126,0.276700547029005
27,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,21,Down,0.0118321945345757,0.326764628005784
28,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.0126035243467816,0.326764628005784
29,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,12,Down,0.0127425143570038,0.326764628005784
30,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,78,Down,0.012988340362694,0.326764628005784
31,WP_DRAVET_SYNDROME,14,Down,0.0130009714628517,0.326764628005784
32,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.0135453520466321,0.326764628005784
33,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.013692938734951,0.326764628005784
34,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.0137306930680776,0.326764628005784
35,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Down,0.0139133357423387,0.326764628005784
36,WP_RETT_SYNDROME,34,Down,0.0147472482509307,0.336728835062918
37,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,24,Up,0.0153080460979631,0.340086861960153
38,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,11,Down,0.0166190848715127,0.359497046431144
39,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,32,Down,0.0174390283315544,0.367561058680453
40,WP_RANKLRANK_SIGNALING,48,Down,0.0180763051090188,0.371468069990337
41,WP_DOPAMINE_METABOLISM,7,Up,0.0201774571811052,0.38273223700285
42,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,36,Down,0.0207068635511576,0.38273223700285
43,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.0212705263613866,0.38273223700285
44,WP_OREXIN_RECEPTOR_PATHWAY,120,Down,0.0213076820011357,0.38273223700285
45,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,33,Up,0.0214797080026727,0.38273223700285
46,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.0222224312273502,0.38273223700285
47,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.022546193242349,0.38273223700285
48,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.022601050885968,0.38273223700285
49,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,50,Down,0.0228149387021163,0.38273223700285
50,WP_IRON_METABOLISM_IN_PLACENTA,10,Down,0.0241767006033782,0.384597472348901
51,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.0242715697976823,0.384597472348901
52,WP_ARYLAMINE_METABOLISM,1,Up,0.0244090130862611,0.384597472348901
53,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,18,Down,0.0247976472439072,0.384597472348901
54,WP_FOXP3_IN_COVID19,10,Down,0.0256402205478294,0.390301135005847
55,WP_METHYLATION_PATHWAYS,5,Up,0.0272665102076918,0.401230727223219
56,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.0273344534361317,0.401230727223219
57,WP_WNT_SIGNALING_WP363,39,Down,0.0281576614896895,0.402542202396446
58,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Down,0.0284032210936665,0.402542202396446
59,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Down,0.0301070145753642,0.409915598728217
60,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,36,Down,0.0307146301335219,0.409915598728217
61,WP_COMPLEMENT_AND_COAGULATION_CASCADES,26,Up,0.0309182081765808,0.409915598728217
62,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,26,Up,0.0309182081765808,0.409915598728217
63,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.0322975930145116,0.416314431282422
64,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,21,Down,0.0324137756716241,0.416314431282422
65,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,19,Down,0.0336194884518297,0.419592118531142
66,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,41,Down,0.0340705454918881,0.419592118531142
67,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.0344681930753895,0.419592118531142
68,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,13,Up,0.035721181411981,0.419592118531142
69,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.0357495990883654,0.419592118531142
70,WP_HEME_BIOSYNTHESIS,8,Down,0.0357495990883654,0.419592118531142
71,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,14,Down,0.0366758863376267,0.419592118531142
72,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Down,0.0367525943238956,0.419592118531142
73,WP_IRON_METABOLISM_DISORDERS,13,Down,0.0380235626151736,0.428155732461269
74,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.0388411999259603,0.431452247826208
75,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,39,Down,0.0416590121101085,0.45367313897507
76,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,23,Down,0.0419454483723909,0.45367313897507
77,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,9,Down,0.0429673328441948,0.458690228544521
78,WP_GALANIN_RECEPTOR_PATHWAY,12,Down,0.0443808823934705,0.467706222146574
79,WP_HYPERTROPHY_MODEL,14,Down,0.0476676120735377,0.495984520562633
80,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.0491428932241821,0.504943227878471
81,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,106,Down,0.0508964422289319,0.516504635952865
82,WP_NUCLEAR_RECEPTORS,20,Down,0.0515692149377211,0.516949935107399
83,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.0560822758290518,0.541409913251856
84,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.0569376137575301,0.541409913251856
85,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Down,0.0572914805654711,0.541409913251856
86,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,5,Down,0.0576457227668454,0.541409913251856
87,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,27,Down,0.0579257685536488,0.541409913251856
88,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,0.0586097074681498,0.541409913251856
89,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.0586198081258092,0.541409913251856
90,WP_SEROTONIN_AND_ANXIETY,7,Down,0.0606926259301525,0.54851537239053
91,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,20,Down,0.0620943228486602,0.54851537239053
92,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.0628443608536274,0.54851537239053
93,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,49,Down,0.0628648044099715,0.54851537239053
94,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,9,Down,0.064218926368328,0.54851537239053
95,WP_LUNG_PATHOLOGY_OF_COVID19,16,Down,0.0646467682552686,0.54851537239053
96,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,87,Up,0.0650921969698917,0.54851537239053
97,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Down,0.0661436565298882,0.54851537239053
98,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,8,Down,0.0678723979082816,0.54851537239053
99,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,20,Down,0.0682697595020481,0.54851537239053
100,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,65,Down,0.0686032674116766,0.54851537239053
101,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,7,Up,0.0690184975055097,0.54851537239053
102,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.0694567324533845,0.54851537239053
103,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.0699435994199545,0.54851537239053
104,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.0700536134148527,0.54851537239053
105,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,41,Down,0.0700658322396663,0.54851537239053
106,WP_GASTRIC_CANCER_NETWORK_2,27,Down,0.0722554474922046,0.556195177105544
107,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Down,0.0724001021293104,0.556195177105544
108,WP_AFLATOXIN_B1_METABOLISM,3,Down,0.0733782391469138,0.558489931284844
109,WP_PLEURAL_MESOTHELIOMA,260,Down,0.0743850590093889,0.559257374457876
110,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,25,Down,0.0751314539874367,0.559257374457876
111,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.0755201564048956,0.559257374457876
112,WP_OSTEOCLAST_SIGNALING,9,Up,0.0768617525905029,0.562679501705348
113,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,33,Down,0.0777597004169505,0.562679501705348
114,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,54,Down,0.0784311024483434,0.562679501705348
115,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.0791593352611252,0.562679501705348
116,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.0800542247608965,0.562679501705348
117,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,0.0800894181259437,0.562679501705348
118,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.0826361266373062,0.567179126318308
119,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Down,0.0834483043595573,0.567179126318308
120,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.0842516739218217,0.567179126318308
121,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.0847787289527209,0.567179126318308
122,WP_INSULIN_SIGNALING,132,Down,0.0859936934938659,0.567179126318308
123,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.0860169179588378,0.567179126318308
124,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,89,Down,0.0874414815020156,0.567179126318308
125,WP_SERINE_METABOLISM,8,Up,0.0876524190610054,0.567179126318308
126,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.0876711757261767,0.567179126318308
127,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,12,Up,0.0880499100393747,0.567179126318308
128,WP_IL18_SIGNALING,194,Down,0.0883198639522426,0.567179126318308
129,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,18,Down,0.0909865288360888,0.576176888529913
130,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.0911760895719295,0.576176888529913
131,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.0918238107024558,0.576176888529913
132,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,18,Down,0.0941584964241773,0.580437947256051
133,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.0941647187006216,0.580437947256051
134,WP_INTEGRINMEDIATED_CELL_ADHESION,72,Down,0.0946212712071907,0.580437947256051
135,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,61,Down,0.0955117618526032,0.581560505502517
136,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.0975766617428468,0.582626831379014
137,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.098202435414875,0.582626831379014
138,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.0984375273505796,0.582626831379014
139,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,42,Up,0.10067588750211,0.582626831379014
140,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.101169469937719,0.582626831379014
141,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.101169469937719,0.582626831379014
142,WP_AMINO_ACID_METABOLISM,59,Up,0.101343607287015,0.582626831379014
143,WP_TAMOXIFEN_METABOLISM,2,Up,0.102181526136585,0.582626831379014
144,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.102505230782679,0.582626831379014
145,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.102774806021846,0.582626831379014
146,WP_MACROPHAGE_MARKERS,9,Down,0.103556587517358,0.583037773556634
147,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.105429844476969,0.583413456632278
148,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,39,Up,0.10651983141846,0.583413456632278
149,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.106691641607034,0.583413456632278
150,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,20,Down,0.108434035111858,0.583413456632278
151,WP_PROLACTIN_SIGNALING,69,Down,0.108711938362214,0.583413456632278
152,WP_ERBB_SIGNALING,69,Down,0.110397421503015,0.583413456632278
153,WP_LUNG_FIBROSIS,34,Down,0.110637938353465,0.583413456632278
154,WP_TCELL_RECEPTOR_SIGNALING,75,Down,0.111858491309466,0.583413456632278
155,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.111968677266002,0.583413456632278
156,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,4,Down,0.113824046252942,0.583413456632278
157,WP_GASTRIN_SIGNALING,93,Down,0.11427633777298,0.583413456632278
158,WP_SELENIUM_MICRONUTRIENT_NETWORK,50,Down,0.11440962666412,0.583413456632278
159,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.115096237305436,0.583413456632278
160,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.115262460926183,0.583413456632278
161,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,26,Up,0.115292607648096,0.583413456632278
162,WP_SYNAPTIC_VESICLE_PATHWAY,21,Down,0.115344564904235,0.583413456632278
163,WP_B_CELL_RECEPTOR_SIGNALING,87,Down,0.115689043103481,0.583413456632278
164,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.117769687560469,0.589284561384819
165,WP_CILIOPATHIES,132,Up,0.118287046993303,0.589284561384819
166,WP_MAPK_SIGNALING,165,Down,0.119058365838336,0.589554076621157
167,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,23,Down,0.120017737497671,0.590745989359792
168,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.122453681250174,0.595163002749539
169,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,64,Up,0.122856848542592,0.595163002749539
170,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,141,Down,0.123616719403361,0.595163002749539
171,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,7,Down,0.123811281593882,0.595163002749539
172,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,16,Down,0.126598614945384,0.602678862492487
173,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.127242502083767,0.602678862492487
174,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,16,Down,0.128503849535376,0.602678862492487
175,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.128905889309613,0.602678862492487
176,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.130149521036978,0.602678862492487
177,WP_LIPID_PARTICLES_COMPOSITION,5,Down,0.131511860700886,0.602678862492487
178,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.131745068025381,0.602678862492487
179,WP_PURINE_METABOLISM,10,Down,0.132557589211054,0.602678862492487
180,WP_ADIPOGENESIS,86,Down,0.134475454170162,0.602678862492487
181,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.135058030072222,0.602678862492487
182,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.135095866371974,0.602678862492487
183,WP_MEVALONATE_PATHWAY,7,Up,0.136102188264193,0.602678862492487
184,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,56,Down,0.136203375478366,0.602678862492487
185,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Up,0.136931624719207,0.602678862492487
186,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,11,Down,0.137338405001307,0.602678862492487
187,WP_GLYOXYLATE_METABOLISM,5,Up,0.13735906558137,0.602678862492487
188,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.137838961251323,0.602678862492487
189,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,49,Down,0.139099740922703,0.604973476393979
190,WP_PREIMPLANTATION_EMBRYO,21,Down,0.140275674671345,0.606876866209713
191,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Down,0.141490396617788,0.608764916487241
192,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.142193265164903,0.608764916487241
193,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.143338654892749,0.610488986123523
194,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.144810633441068,0.61237844965607
195,WP_SILDENAFIL_TREATMENT,11,Down,0.145272259954907,0.61237844965607
196,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.146858543846449,0.615906750213171
197,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Up,0.148549550255542,0.619836194467285
198,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.150154520838639,0.623368768330108
199,WP_EGFEGFR_SIGNALING,142,Down,0.153173194038574,0.632400818380292
200,WP_JOUBERT_SYNDROME,71,Up,0.154296510916036,0.632400818380292
201,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,0.155148947257621,0.632400818380292
202,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.155407500380558,0.632400818380292
203,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.156743877315446,0.634696882528556
204,WP_SPINA_BIFIDA,11,Down,0.15851434778329,0.63502953983755
205,WP_10Q22Q23_COPY_NUMBER_VARIATION,28,Up,0.159331630603732,0.63502953983755
206,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,45,Down,0.159554865498735,0.63502953983755
207,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.159916197988288,0.63502953983755
208,WP_BENZOAPYRENE_METABOLISM,5,Up,0.162534176741411,0.642322563853075
209,WP_ENDOTHELIN_PATHWAYS,13,Up,0.166393603992685,0.65345107932489
210,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.166940056761833,0.65345107932489
211,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.169709250172974,0.657822090791324
212,WP_IRINOTECAN_PATHWAY,5,Up,0.17100254734318,0.657822090791324
213,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,38,Up,0.171271492744332,0.657822090791324
214,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.174945114534182,0.657822090791324
215,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.174965055455228,0.657822090791324
216,WP_BARDETBIEDL_SYNDROME,66,Up,0.175821768324819,0.657822090791324
217,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.176186143237461,0.657822090791324
218,WP_TP53_NETWORK,17,Down,0.17659657534396,0.657822090791324
219,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,4,Down,0.178498367434214,0.657822090791324
220,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.17921430775263,0.657822090791324
221,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.179424583070924,0.657822090791324
222,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,50,Down,0.179499482527166,0.657822090791324
223,WP_KLEEFSTRA_SYNDROME,24,Down,0.180542106093157,0.657822090791324
224,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.181291894852011,0.657822090791324
225,WP_SMALL_CELL_LUNG_CANCER,72,Down,0.18248027105247,0.657822090791324
226,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,53,Down,0.182910119193814,0.657822090791324
227,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.18296722437201,0.657822090791324
228,WP_ENDODERM_DIFFERENTIATION,82,Down,0.183500996272042,0.657822090791324
229,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,79,Down,0.183713120810111,0.657822090791324
230,WP_IL1_SIGNALING,53,Down,0.184976742239686,0.657822090791324
231,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.185438094648711,0.657822090791324
232,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.185662682559108,0.657822090791324
233,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.188882962967188,0.666188503656398
234,WP_ALSTROM_SYNDROME,27,Up,0.189644902500726,0.666188503656398
235,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,38,Down,0.191769363256542,0.667965350961387
236,WP_NAD_METABOLISM,12,Down,0.191775940178695,0.667965350961387
237,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Up,0.193822350473894,0.671461769330508
238,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,42,Down,0.194413504988639,0.671461769330508
239,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,2,Up,0.196527928109794,0.674925559004962
240,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.197953582120049,0.674925559004962
241,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.200543179217039,0.674925559004962
242,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,15,Up,0.200814114979875,0.674925559004962
243,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,30,Down,0.201370111096329,0.674925559004962
244,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.201517693008648,0.674925559004962
245,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.201927190262077,0.674925559004962
246,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,25,Down,0.201985021308054,0.674925559004962
247,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,6,Up,0.206415548323967,0.685286529810906
248,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,86,Down,0.208557933243185,0.685286529810906
249,WP_OPIOID_RECEPTOR_PATHWAYS,26,Down,0.208692771376065,0.685286529810906
250,WP_KETOGENESIS_AND_KETOLYSIS,7,Up,0.20939574842754,0.685286529810906
251,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.20957162411571,0.685286529810906
252,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.210087841255898,0.685286529810906
253,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.212180006264898,0.687212320298789
254,WP_TLR4_SIGNALING_AND_TOLERANCE,27,Down,0.212539677119691,0.687212320298789
255,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,84,Down,0.213186303742325,0.687212320298789
256,WP_TYPE_II_INTERFERON_SIGNALING,30,Up,0.214715549840344,0.689438210815481
257,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.215698379397388,0.689899096749624
258,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Up,0.220779694465422,0.699001704500764
259,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.22099273019984,0.699001704500764
260,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.221147233324885,0.699001704500764
261,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.222363603836052,0.699001704500764
262,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,25,Down,0.223797895939284,0.699001704500764
263,WP_OVARIAN_INFERTILITY,24,Down,0.224361453722076,0.699001704500764
264,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Down,0.225306777809542,0.699001704500764
265,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.225347264832971,0.699001704500764
266,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,26,Down,0.229932829887538,0.70615987595343
267,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.230744450788025,0.70615987595343
268,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.231354960910305,0.70615987595343
269,WP_NEPHROGENESIS,4,Down,0.231371700883343,0.70615987595343
270,WP_TOLLLIKE_RECEPTOR_SIGNALING,81,Down,0.232183984059523,0.70615987595343
271,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Down,0.233791674401508,0.70615987595343
272,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Up,0.234654183363801,0.70615987595343
273,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,13,Down,0.234911434021302,0.70615987595343
274,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Down,0.23538662531781,0.70615987595343
275,WP_KREBS_CYCLE_DISORDERS,11,Up,0.237725756616157,0.710583897958114
276,WP_KALLMANN_SYNDROME,12,Up,0.243925511341381,0.726473805516721
277,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.247660521135755,0.733710608919471
278,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.248707715465466,0.733710608919471
279,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,16,Down,0.250227040865751,0.733710608919471
280,WP_UROTENSINIIMEDIATED_SIGNALING,51,Down,0.250332386738057,0.733710608919471
281,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.251023595318107,0.733710608919471
282,WP_CIRCADIAN_RHYTHM_GENES,121,Down,0.252712801775843,0.733710608919471
283,WP_SMALL_LIGAND_GPCRS,7,Up,0.253549760304838,0.733710608919471
284,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.254085794993644,0.733710608919471
285,WP_CAMKK2_PATHWAY,30,Down,0.254388714771349,0.733710608919471
286,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,37,Up,0.255607239619676,0.734647381004803
287,WP_KIT_RECEPTOR_SIGNALING,53,Down,0.257788838989756,0.738335977873099
288,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,19,Down,0.258809640739446,0.738685849610503
289,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Up,0.262862438640629,0.74765717841729
290,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Down,0.270262136289504,0.76168635924859
291,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.270797097487763,0.76168635924859
292,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.272345137115105,0.76168635924859
293,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Down,0.272596319274765,0.76168635924859
294,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Down,0.272596319274765,0.76168635924859
295,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.274081764279828,0.76168635924859
296,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,44,Down,0.274281219388787,0.76168635924859
297,WP_NEUROINFLAMMATION,10,Down,0.275525844418546,0.762566478491734
298,WP_FERROPTOSIS,50,Up,0.279655943016189,0.771399950199017
299,WP_REGULATION_OF_ACTIN_CYTOSKELETON,93,Down,0.281324471885393,0.773407076554491
300,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,25,Down,0.283397646654507,0.776509551833348
301,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.284985506959917,0.778266068840703
302,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Down,0.290081108421819,0.788344748200699
303,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,87,Down,0.29090862755735,0.788344748200699
304,WP_NEURAL_CREST_DIFFERENTIATION,40,Down,0.291553288872278,0.788344748200699
305,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.293411708970155,0.790768605814646
306,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.298068095470527,0.800565238115791
307,WP_SLEEP_REGULATION,11,Down,0.298994559734243,0.800565238115791
308,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,30,Down,0.300187743697617,0.801150406881304
309,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.302877046883417,0.805711755786955
310,WP_TNFALPHA_SIGNALING,85,Down,0.30643356017341,0.811591516945547
311,WP_16P112_DISTAL_DELETION_SYNDROME,22,Down,0.307061997287184,0.811591516945547
312,WP_FOXA2_PATHWAY,9,Down,0.308468151743902,0.812694938248356
313,WP_PRIMARY_OVARIAN_INSUFFICIENCY,98,Down,0.310293703643899,0.814338766205527
314,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Up,0.311073445971454,0.814338766205527
315,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,54,Up,0.313189166393284,0.815291222175588
316,WP_CILIARY_LANDSCAPE,187,Up,0.313420956456796,0.815291222175588
317,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.315472594665244,0.817072973631821
318,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.31655481247685,0.817072973631821
319,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.317087930156388,0.817072973631821
320,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,63,Down,0.321315942441419,0.823473695086679
321,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Down,0.321575494066696,0.823473695086679
322,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,14,Down,0.322603226439334,0.823539913456934
323,WP_CHEMOKINE_SIGNALING,113,Down,0.328679668996792,0.831696314321211
324,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.328842583418682,0.831696314321211
325,WP_NETRINUNC5B_SIGNALING,35,Down,0.329395158450896,0.831696314321211
326,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.332140159121599,0.831696314321211
327,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,11,Down,0.332285135259486,0.831696314321211
328,WP_LEPTIN_SIGNALING,70,Down,0.3348413005511,0.831696314321211
329,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.335613954823828,0.831696314321211
330,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.337073309937225,0.831696314321211
331,WP_METABOLIC_EPILEPTIC_DISORDERS,60,Up,0.337530466261422,0.831696314321211
332,WP_4P163_COPY_NUMBER_VARIATION,22,Up,0.338442036194014,0.831696314321211
333,WP_BLADDER_CANCER,29,Down,0.339772118383361,0.831696314321211
334,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,99,Down,0.341115275580455,0.831696314321211
335,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,50,Down,0.341316161508382,0.831696314321211
336,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,6,Down,0.341594112024052,0.831696314321211
337,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.343125739088634,0.831696314321211
338,WP_7OXOC_AND_7BETAHC_PATHWAYS,17,Up,0.343748522904252,0.831696314321211
339,WP_ENERGY_METABOLISM,42,Down,0.344555523565271,0.831696314321211
340,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,68,Down,0.346918325451511,0.831696314321211
341,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,24,Down,0.348107003757046,0.831696314321211
342,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Up,0.352380287374283,0.831696314321211
343,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Down,0.3533091396892,0.831696314321211
344,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,10,Up,0.35333418235218,0.831696314321211
345,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,20,Down,0.354599410542984,0.831696314321211
346,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Down,0.356320889949574,0.831696314321211
347,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.35819145110021,0.831696314321211
348,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,14,Up,0.360219243698477,0.831696314321211
349,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.360426422987434,0.831696314321211
350,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.360572287968421,0.831696314321211
351,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.360572287968421,0.831696314321211
352,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.361026634142883,0.831696314321211
353,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.361543137474513,0.831696314321211
354,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,178,Down,0.362267545635386,0.831696314321211
355,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.362557728530688,0.831696314321211
356,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.363746379954919,0.831696314321211
357,WP_ECTODERM_DIFFERENTIATION,79,Down,0.363816820771288,0.831696314321211
358,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.363992112151904,0.831696314321211
359,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.36429300689253,0.831696314321211
360,WP_TRANSLATION_FACTORS,49,Down,0.364304469126765,0.831696314321211
361,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.365258357019412,0.831696314321211
362,WP_PRION_DISEASE_PATHWAY,28,Up,0.369245248121,0.838217886875337
363,WP_PEPTIDE_GPCRS,13,Up,0.371479380954624,0.838217886875337
364,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.371776748247133,0.838217886875337
365,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.375027465755261,0.838217886875337
366,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.375560795990938,0.838217886875337
367,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.375895928836607,0.838217886875337
368,WP_ALLOGRAFT_REJECTION,50,Down,0.37653417436465,0.838217886875337
369,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.377836112317494,0.838217886875337
370,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.377855556479481,0.838217886875337
371,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.379891423583256,0.838217886875337
372,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,13,Down,0.383388275823173,0.838217886875337
373,WP_NEOVASCULARIZATION_PROCESSES,23,Down,0.383621741496394,0.838217886875337
374,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Up,0.384399492725551,0.838217886875337
375,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Down,0.384737986353529,0.838217886875337
376,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,33,Down,0.386364451384802,0.838217886875337
377,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Down,0.387265336362314,0.838217886875337
378,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.388272919932275,0.838217886875337
379,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,23,Up,0.388668818542179,0.838217886875337
380,WP_VITAMIN_D_RECEPTOR_PATHWAY,86,Down,0.389337680025637,0.838217886875337
381,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,86,Down,0.390372592511148,0.838217886875337
382,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.390937937233816,0.838217886875337
383,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.391467487387772,0.838217886875337
384,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.391576239124245,0.838217886875337
385,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,5,Down,0.393534744409971,0.839938854466314
386,WP_FATTY_ACID_BETAOXIDATION,29,Up,0.394570559693484,0.839938854466314
387,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Down,0.395571341112939,0.839938854466314
388,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,76,Down,0.397364535633657,0.839938854466314
389,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.398289458340315,0.839938854466314
390,WP_IDO_METABOLIC_PATHWAY,7,Down,0.399210966209821,0.839938854466314
391,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.399532958754658,0.839938854466314
392,WP_COMPLEMENT_ACTIVATION,12,Up,0.40283250900048,0.844715108159171
393,WP_IL9_SIGNALING,15,Up,0.405235639844341,0.847592101659156
394,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.407072562533587,0.848600109127059
395,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.407782290882224,0.848600109127059
396,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,11,Up,0.409181712839987,0.848607124759037
397,WP_TGFB_SMAD_SIGNALING,7,Down,0.410681778944999,0.848607124759037
398,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Down,0.411118515125504,0.848607124759037
399,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,62,Down,0.411915137200554,0.848607124759037
400,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,52,Down,0.415035443659724,0.851176854103535
401,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,19,Down,0.416127537358079,0.851176854103535
402,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,22,Down,0.417272822116361,0.851176854103535
403,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Up,0.417304467401125,0.851176854103535
404,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.419785786693847,0.854118605599857
405,WP_AGERAGE_PATHWAY,54,Down,0.422917313190459,0.856013204297123
406,WP_FOCAL_ADHESION,118,Down,0.423455067663861,0.856013204297123
407,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Down,0.424570273296056,0.856013204297123
408,WP_ALPHA_6_BETA_4_SIGNALING,25,Down,0.424882466366455,0.856013204297123
409,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,21,Down,0.427997225301814,0.858693564285767
410,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.428595189535645,0.858693564285767
411,WP_INFLAMMATORY_RESPONSE_PATHWAY,13,Down,0.429346782142883,0.858693564285767
412,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Down,0.431547028186339,0.860999167886337
413,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.432790123851905,0.861059009035325
414,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.434416013209466,0.861059009035325
415,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.434719572688151,0.861059009035325
416,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Up,0.436496605763603,0.862500504657889
417,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Down,0.440408998292912,0.862859905160468
418,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.440416440013835,0.862859905160468
419,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.440595062098989,0.862859905160468
420,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.440877323804619,0.862859905160468
421,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.443712970440279,0.864657571793667
422,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.444215384278866,0.864657571793667
423,WP_MEASLES_VIRUS_INFECTION,105,Up,0.444951524171194,0.864657571793667
424,WP_CORI_CYCLE,11,Down,0.448556420745122,0.866992099432523
425,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.448595271357065,0.866992099432523
426,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.450657390546105,0.866992099432523
427,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.45214197420121,0.866992099432523
428,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.452674342519276,0.866992099432523
429,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,72,Down,0.454060926854049,0.866992099432523
430,WP_MONOAMINE_GPCRS,3,Down,0.454323490283733,0.866992099432523
431,WP_MELANOMA,56,Down,0.454714186754329,0.866992099432523
432,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.455645482913443,0.866992099432523
433,WP_13Q1212_COPY_NUMBER_VARIATION,21,Down,0.459314676395841,0.871955344104808
434,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Down,0.463530148475856,0.875468044475284
435,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,70,Down,0.46400686178678,0.875468044475284
436,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,42,Down,0.464863794406359,0.875468044475284
437,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.466448990514147,0.875468044475284
438,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Down,0.46825676039452,0.875468044475284
439,WP_HIPPO_SIGNALING_REGULATION,45,Down,0.468300236585519,0.875468044475284
440,WP_MAPK_CASCADE,30,Down,0.468908709600472,0.875468044475284
441,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.470513967373691,0.875468044475284
442,WP_MICROTUBULE_CYTOSKELETON_REGULATION,37,Down,0.470750457004958,0.875468044475284
443,WP_CHOLESTASIS,9,Up,0.472333280906475,0.876428796625559
444,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Down,0.474819812535396,0.8785055542415
445,WP_APOPTOSIS_MODULATION_AND_SIGNALING,79,Down,0.475816510029027,0.8785055542415
446,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.476658731376775,0.8785055542415
447,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.480613918402598,0.883813514377931
448,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.482258987536996,0.884859124454042
449,WP_ACUTE_MYELOID_LEUKEMIA,57,Up,0.484298744571046,0.884871705199471
450,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Up,0.486017378701519,0.884871705199471
451,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,11,Down,0.489499697751344,0.884871705199471
452,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.491239062715774,0.884871705199471
453,WP_HEPATITIS_B_INFECTION,120,Down,0.491686359576509,0.884871705199471
454,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Down,0.491990706379636,0.884871705199471
455,WP_TGFBETA_RECEPTOR_SIGNALING,35,Down,0.493044690485363,0.884871705199471
456,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,52,Down,0.493810718593968,0.884871705199471
457,WP_P38_MAPK_SIGNALING,31,Down,0.493919448714464,0.884871705199471
458,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Down,0.493978766206229,0.884871705199471
459,WP_ONCOSTATIN_M_SIGNALING,55,Down,0.494589044521224,0.884871705199471
460,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.498014648033506,0.884871705199471
461,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.498114901776104,0.884871705199471
462,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.49937540116903,0.884871705199471
463,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,40,Up,0.499420057932104,0.884871705199471
464,WP_APOPTOSIS,73,Down,0.500897618570249,0.884871705199471
465,WP_IL4_SIGNALING,51,Down,0.501111242380992,0.884871705199471
466,WP_NUCLEAR_RECEPTORS_METAPATHWAY,179,Down,0.502955299425371,0.884871705199471
467,WP_ULCERATIVE_COLITIS_SIGNALING,12,Down,0.504811075581485,0.884871705199471
468,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.505530570096155,0.884871705199471
469,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,14,Up,0.506080564216856,0.884871705199471
470,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Down,0.506310014927772,0.884871705199471
471,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,50,Down,0.508062519468498,0.884871705199471
472,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,79,Down,0.508101514421108,0.884871705199471
473,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.509807421569538,0.885172428445217
474,WP_ESTROGEN_SIGNALING,21,Down,0.510427896694687,0.885172428445217
475,WP_ENDOCHONDRAL_OSSIFICATION,28,Up,0.515761764442166,0.890664223469454
476,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,28,Up,0.515761764442166,0.890664223469454
477,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.517478342179,0.890794718269017
478,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.518004714516533,0.890794718269017
479,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,50,Down,0.52000681456759,0.891717494052053
480,WP_PDGF_PATHWAY,37,Down,0.522246402039842,0.891717494052053
481,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Up,0.522722208116781,0.891717494052053
482,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.523093413929862,0.891717494052053
483,WP_VITAMIN_B12_DISORDERS,9,Down,0.524332542123499,0.891717494052053
484,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,17,Down,0.525050203310454,0.891717494052053
485,WP_HIPPOYAP_SIGNALING,17,Down,0.528082693127537,0.895018502579042
486,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.535134007227671,0.905103197409765
487,WP_PYRIMIDINE_METABOLISM,77,Down,0.542008816133904,0.908840725305692
488,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.54226456667043,0.908840725305692
489,WP_BENZENE_METABOLISM,4,Up,0.543109318233423,0.908840725305692
490,WP_ONECARBON_METABOLISM,24,Down,0.5431124358913,0.908840725305692
491,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.543725169941184,0.908840725305692
492,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.543977660401947,0.908840725305692
493,WP_GPCRS_CLASS_A_RHODOPSINLIKE,41,Down,0.547348094512211,0.910420976811467
494,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.549990982221331,0.910420976811467
495,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,79,Up,0.550235706558422,0.910420976811467
496,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Down,0.550604239704317,0.910420976811467
497,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.550710395258227,0.910420976811467
498,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,8,Down,0.553421417193572,0.910420976811467
499,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,49,Down,0.554184906193742,0.910420976811467
500,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.55492729598747,0.910420976811467
501,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,65,Up,0.555473924289355,0.910420976811467
502,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,79,Down,0.555999185352015,0.910420976811467
503,WP_HEART_DEVELOPMENT,17,Up,0.56065571980317,0.916220679280727
504,WP_MRNA_PROCESSING,124,Down,0.564003697648238,0.918331384573137
505,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.564181690035808,0.918331384573137
506,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,38,Down,0.568871818163407,0.923314472019541
507,WP_EBOLA_VIRUS_INFECTION_IN_HOST,108,Down,0.569489583106943,0.923314472019541
508,WP_PPAR_SIGNALING,38,Up,0.57072416560561,0.923494614424826
509,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.575900771047494,0.9295573036075
510,WP_COMPLEMENT_SYSTEM,52,Up,0.577193931395076,0.9295573036075
511,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.578479718947558,0.9295573036075
512,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.578994330227543,0.9295573036075
513,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.582192186417186,0.931826144089383
514,WP_G_PROTEIN_SIGNALING,64,Up,0.584153564989894,0.931826144089383
515,WP_CCL18_SIGNALING,22,Down,0.584660209013712,0.931826144089383
516,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.586981608407006,0.931826144089383
517,WP_PURINERGIC_SIGNALING,15,Up,0.588477987960425,0.931826144089383
518,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Up,0.588487278155145,0.931826144089383
519,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.588635281310241,0.931826144089383
520,WP_KININKALLIKREIN_PATHWAY,2,Up,0.589476392854598,0.931826144089383
521,WP_ANGIOGENESIS,14,Down,0.59199846013272,0.933010452200837
522,WP_TRYPTOPHAN_METABOLISM,18,Up,0.594077770411037,0.933010452200837
523,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Up,0.594444885427328,0.933010452200837
524,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Down,0.598432820315095,0.933010452200837
525,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.599709024255207,0.933010452200837
526,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.600024376627682,0.933010452200837
527,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.600236326936936,0.933010452200837
528,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.60078766108395,0.933010452200837
529,WP_MALE_INFERTILITY,72,Up,0.602148973969559,0.933010452200837
530,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,35,Up,0.602690690340671,0.933010452200837
531,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,58,Down,0.604018300798508,0.933010452200837
532,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,15,Down,0.604827326821486,0.933010452200837
533,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Up,0.604981229955044,0.933010452200837
534,WP_15Q11Q13_COPY_NUMBER_VARIATION,34,Up,0.608927315287521,0.935128175362845
535,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,17,Up,0.61078865676026,0.935128175362845
536,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,16,Down,0.611719700276582,0.935128175362845
537,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.612240112390151,0.935128175362845
538,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Up,0.613649554986611,0.935128175362845
539,WP_IL5_SIGNALING,37,Down,0.614601634606793,0.935128175362845
540,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,12,Down,0.61635872415024,0.935128175362845
541,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Up,0.616402149784103,0.935128175362845
542,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.616881245477642,0.935128175362845
543,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,56,Down,0.620252985724694,0.935128175362845
544,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,21,Up,0.620795774514605,0.935128175362845
545,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,64,Up,0.621529576428487,0.935128175362845
546,WP_INTEGRATED_CANCER_PATHWAY,42,Down,0.621545213585745,0.935128175362845
547,WP_DNA_MISMATCH_REPAIR,23,Down,0.625516318294119,0.935128175362845
548,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,34,Up,0.626497833780113,0.935128175362845
549,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,14,Down,0.626579528102823,0.935128175362845
550,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.627069612935392,0.935128175362845
551,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,57,Up,0.627495374996567,0.935128175362845
552,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Up,0.629952481649215,0.935128175362845
553,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.62997532807371,0.935128175362845
554,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.630448522718763,0.935128175362845
555,WP_CELL_CYCLE,110,Up,0.631382162197541,0.935128175362845
556,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,130,Up,0.633952991810167,0.936164721227409
557,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.634359792851176,0.936164721227409
558,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.636435194909051,0.93630689050381
559,WP_PROTEOGLYCAN_BIOSYNTHESIS,16,Up,0.641507214957271,0.93630689050381
560,WP_NOTCH_SIGNALING_WP268,35,Down,0.642529319676976,0.93630689050381
561,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.643506159128292,0.93630689050381
562,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,19,Up,0.644484214149651,0.93630689050381
563,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.646269348631889,0.93630689050381
564,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Up,0.646336567580576,0.93630689050381
565,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.647140194855964,0.93630689050381
566,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,56,Down,0.647727204942696,0.93630689050381
567,WP_DNA_DAMAGE_RESPONSE,63,Up,0.647869514577341,0.93630689050381
568,WP_VEGFAVEGFR2_SIGNALING,349,Down,0.649538085143668,0.93630689050381
569,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.649827103487938,0.93630689050381
570,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.650283843976766,0.93630689050381
571,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.651142000362435,0.93630689050381
572,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Up,0.652596653731721,0.93630689050381
573,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.652681080606671,0.93630689050381
574,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.654329640021552,0.93703652281832
575,WP_NRF2ARE_REGULATION,20,Up,0.655573385521539,0.937184909389052
576,WP_NGLYCAN_BIOSYNTHESIS,52,Up,0.657753798871127,0.938071880441202
577,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Down,0.659400350593095,0.938071880441202
578,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.660089300197658,0.938071880441202
579,WP_OSTEOBLAST_SIGNALING,3,Up,0.660758660310774,0.938071880441202
580,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.662063100878598,0.938303222279669
581,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,3,Down,0.665340749525799,0.94083740181735
582,WP_PROTEASOME_DEGRADATION,57,Up,0.666140350191847,0.94083740181735
583,WP_GLYCOLYSIS_IN_SENESCENCE,10,Down,0.672553449775356,0.947595964542604
584,WP_NAD_BIOSYNTHETIC_PATHWAYS,19,Up,0.673493987191184,0.947595964542604
585,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,8,Up,0.676177800915548,0.947595964542604
586,WP_MIRNA_BIOGENESIS,6,Up,0.676408658240262,0.947595964542604
587,WP_SPHINGOLIPID_PATHWAY,21,Up,0.676951217340247,0.947595964542604
588,WP_EICOSANOID_SYNTHESIS,14,Down,0.678501412262744,0.947595964542604
589,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,23,Down,0.678995161941112,0.947595964542604
590,WP_HUNGER_AND_SATIETY,2,Down,0.682489347516113,0.950032656464957
591,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.684091881893884,0.950032656464957
592,WP_IL19_SIGNALING,21,Up,0.684308334826229,0.950032656464957
593,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.685364191342724,0.950032656464957
594,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.687643893229266,0.950359238162329
595,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,15,Down,0.687912100616284,0.950359238162329
596,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,31,Down,0.692582049154806,0.955176232596197
597,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.693722884257822,0.955176232596197
598,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,58,Up,0.69540600346329,0.95589253318867
599,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.697294581853787,0.956186211059278
600,WP_MESODERMAL_COMMITMENT_PATHWAY,79,Down,0.699562563479222,0.956186211059278
601,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.701651089444797,0.956186211059278
602,WP_WNT_SIGNALING_WP428,62,Down,0.703602557875971,0.956186211059278
603,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,18,Down,0.703691748524436,0.956186211059278
604,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.704394761064739,0.956186211059278
605,WP_FLUOROPYRIMIDINE_ACTIVITY,28,Down,0.704664711464833,0.956186211059278
606,WP_ATM_SIGNALING,38,Down,0.70492560085392,0.956186211059278
607,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.70691888510186,0.957120975665453
608,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,4,Up,0.710235539571231,0.957120975665453
609,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,34,Down,0.71100435825354,0.957120975665453
610,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.712699878709148,0.957120975665453
611,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.713674326835762,0.957120975665453
612,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.715448441577785,0.957120975665453
613,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,28,Down,0.716179507232777,0.957120975665453
614,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.718138369207633,0.957120975665453
615,WP_ENDOMETRIAL_CANCER,49,Down,0.71937757376708,0.957120975665453
616,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.720273562795013,0.957120975665453
617,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,46,Up,0.721856630476437,0.957120975665453
618,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Down,0.722334992861082,0.957120975665453
619,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Down,0.724330019204249,0.957120975665453
620,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.727828787637255,0.957120975665453
621,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,45,Up,0.727889189336044,0.957120975665453
622,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,5,Down,0.732490474439919,0.957120975665453
623,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Down,0.733512717952316,0.957120975665453
624,WP_ZINC_HOMEOSTASIS,24,Up,0.734976311144866,0.957120975665453
625,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,14,Up,0.735021984009795,0.957120975665453
626,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.735229888140472,0.957120975665453
627,WP_GASTRIC_CANCER_NETWORK_1,21,Up,0.735572883416437,0.957120975665453
628,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.736860350912614,0.957120975665453
629,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.739012223563752,0.957120975665453
630,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,7,Down,0.741345332485983,0.957120975665453
631,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,52,Down,0.742132889492811,0.957120975665453
632,WP_CREATINE_PATHWAY,3,Down,0.742214886758057,0.957120975665453
633,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.743931378440001,0.957120975665453
634,WP_WNT_SIGNALING_AND_PLURIPOTENCY,61,Up,0.745717186678966,0.957120975665453
635,WP_IL3_SIGNALING,46,Down,0.746422128523813,0.957120975665453
636,WP_MATRIX_METALLOPROTEINASES,8,Up,0.74704679682119,0.957120975665453
637,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.748016339145259,0.957120975665453
638,WP_IL7_SIGNALING,23,Up,0.748503772368608,0.957120975665453
639,WP_NUCLEOTIDE_GPCRS,5,Up,0.75090439885369,0.957120975665453
640,WP_NRXN1_DELETION_SYNDROME,2,Down,0.751823048863579,0.957120975665453
641,WP_FRAGILE_X_SYNDROME,84,Down,0.753743864237448,0.957120975665453
642,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.755297337428035,0.957120975665453
643,WP_NONSMALL_CELL_LUNG_CANCER,62,Down,0.759890694657417,0.957120975665453
644,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,53,Down,0.760286987429541,0.957120975665453
645,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,17,Down,0.761678274630251,0.957120975665453
646,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.762434137940815,0.957120975665453
647,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.762558919229635,0.957120975665453
648,WP_ALZHEIMERS_DISEASE,188,Down,0.764362288309756,0.957120975665453
649,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,188,Down,0.764362288309756,0.957120975665453
650,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.764794096289571,0.957120975665453
651,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,19,Up,0.768073964890621,0.957120975665453
652,WP_NRF2_PATHWAY,72,Up,0.768926070202866,0.957120975665453
653,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,15,Up,0.770719611175693,0.957120975665453
654,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Up,0.775086636718042,0.957120975665453
655,WP_RAS_SIGNALING,118,Down,0.775100785867522,0.957120975665453
656,WP_TAR_SYNDROME,46,Down,0.775293789943038,0.957120975665453
657,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.777110990076809,0.957120975665453
658,WP_ESTROGEN_METABOLISM_WP697,6,Up,0.779801895277389,0.957120975665453
659,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Down,0.779973384363874,0.957120975665453
660,WP_DISORDERS_IN_KETOLYSIS,5,Up,0.782467691740792,0.957120975665453
661,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.783993680092258,0.957120975665453
662,WP_IL10_ANTIINFLAMMATORY_SIGNALING,11,Down,0.784759633993668,0.957120975665453
663,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.784953934783145,0.957120975665453
664,WP_AUTOPHAGY,27,Down,0.785443684153038,0.957120975665453
665,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,62,Down,0.787164707842136,0.957120975665453
666,WP_NUCLEOTIDE_EXCISION_REPAIR,44,Down,0.789360306845028,0.957120975665453
667,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Up,0.790022658558176,0.957120975665453
668,WP_GLIOBLASTOMA_SIGNALING,69,Down,0.790969922317535,0.957120975665453
669,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,11,Down,0.79238808117416,0.957120975665453
670,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.792871720044532,0.957120975665453
671,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,166,Up,0.793249380793306,0.957120975665453
672,WP_PPARALPHA_PATHWAY,15,Up,0.793290525996078,0.957120975665453
673,WP_BASE_EXCISION_REPAIR,31,Down,0.794246501220832,0.957120975665453
674,WP_OSTEOPONTIN_SIGNALING,11,Down,0.795522151798316,0.957120975665453
675,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,17,Up,0.797919473265009,0.957120975665453
676,WP_MTHFR_DEFICIENCY,19,Down,0.79822267382389,0.957120975665453
677,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.798299971257405,0.957120975665453
678,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Up,0.798581632347754,0.957120975665453
679,WP_PHOSPHOINOSITIDES_METABOLISM,39,Down,0.79924816279441,0.957120975665453
680,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Up,0.79960885104479,0.957120975665453
681,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.799725182276166,0.957120975665453
682,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Up,0.800268716214011,0.957120975665453
683,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.802742660057261,0.957120975665453
684,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.804454756584384,0.957120975665453
685,WP_PDGFRBETA_PATHWAY,28,Up,0.807281757909017,0.957120975665453
686,WP_ACE_INHIBITOR_PATHWAY,4,Down,0.807306028573277,0.957120975665453
687,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Down,0.808044739930526,0.957120975665453
688,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.80853987794156,0.957120975665453
689,WP_BLOOD_CLOTTING_CASCADE,7,Up,0.811675633410603,0.957120975665453
690,WP_UREA_CYCLE_AND_RELATED_DISEASES,4,Up,0.812564043541683,0.957120975665453
691,WP_MITOCHONDRIAL_GENE_EXPRESSION,17,Up,0.812737373809865,0.957120975665453
692,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,70,Down,0.81411597067459,0.957120975665453
693,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.815643268171639,0.957120975665453
694,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,46,Down,0.815842643543164,0.957120975665453
695,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Up,0.819220477030645,0.957120975665453
696,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,26,Down,0.8207734761118,0.957120975665453
697,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,48,Down,0.820978908915217,0.957120975665453
698,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,6,Up,0.822789145368563,0.957120975665453
699,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Up,0.823848190396147,0.957120975665453
700,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.824231199288772,0.957120975665453
701,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.82609366343375,0.957120975665453
702,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.826673017158377,0.957120975665453
703,WP_IL17_SIGNALING,25,Down,0.827092284582343,0.957120975665453
704,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.827408738182053,0.957120975665453
705,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.830638472697259,0.957120975665453
706,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,29,Down,0.831157715918534,0.957120975665453
707,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,18,Up,0.832150428069704,0.957120975665453
708,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.832396438265853,0.957120975665453
709,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,94,Down,0.835383432767221,0.957120975665453
710,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Up,0.835474610850747,0.957120975665453
711,WP_AEROBIC_GLYCOLYSIS,10,Up,0.840036716830416,0.957120975665453
712,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.840036716830416,0.957120975665453
713,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.841082341062042,0.957120975665453
714,WP_RAC1PAK1P38MMP2_PATHWAY,53,Down,0.841112940812578,0.957120975665453
715,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.841342842509313,0.957120975665453
716,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.842212065415689,0.957120975665453
717,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.842582240351098,0.957120975665453
718,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,17,Down,0.843333604379704,0.957120975665453
719,WP_MONOAMINE_TRANSPORT,13,Up,0.843687152561264,0.957120975665453
720,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Up,0.845100390422425,0.957120975665453
721,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.845807194937559,0.957120975665453
722,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.84704861836374,0.957120975665453
723,WP_IL11_SIGNALING,41,Up,0.848051822671788,0.957120975665453
724,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,30,Down,0.85059390961827,0.957120975665453
725,WP_15Q25_COPY_NUMBER_VARIATION,28,Up,0.851246258211483,0.957120975665453
726,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Down,0.851516355942758,0.957120975665453
727,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,119,Up,0.852105535031909,0.957120975665453
728,WP_AXON_GUIDANCE,38,Down,0.852175021863574,0.957120975665453
729,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,7,Up,0.853115200639702,0.957120975665453
730,WP_PANCREATIC_CANCER_SUBTYPES,6,Up,0.855700178614755,0.957120975665453
731,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.856188023893288,0.957120975665453
732,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.856871310704412,0.957120975665453
733,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.856925621181851,0.957120975665453
734,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,13,Down,0.857744023126348,0.957120975665453
735,WP_GLUTATHIONE_METABOLISM,11,Up,0.85777530358472,0.957120975665453
736,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,127,Up,0.858706916667901,0.957120975665453
737,WP_5Q35_COPY_NUMBER_VARIATION,79,Up,0.860329656037511,0.957120975665453
738,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,82,Down,0.861727523438559,0.957120975665453
739,WP_DNA_REPLICATION,42,Down,0.862395342084205,0.957120975665453
740,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Down,0.86272050208188,0.957120975665453
741,WP_G1_TO_S_CELL_CYCLE_CONTROL,59,Down,0.863163442744937,0.957120975665453
742,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,273,Up,0.863970515746674,0.957120975665453
743,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.865283590786726,0.957285479982085
744,WP_HOMOLOGOUS_RECOMBINATION,13,Up,0.868161160536026,0.958959862802472
745,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.869426929047385,0.958959862802472
746,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,18,Down,0.87192550106244,0.958959862802472
747,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.872117478297491,0.958959862802472
748,WP_TRANSSULFURATION_PATHWAY,8,Down,0.87263014279349,0.958959862802472
749,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.87525405238966,0.959572041769549
750,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Up,0.878190222461369,0.959572041769549
751,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,21,Down,0.880605172023485,0.959572041769549
752,WP_NPHP1_DELETION_SYNDROME,10,Up,0.881488041447517,0.959572041769549
753,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.881753579865579,0.959572041769549
754,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Up,0.882098129934694,0.959572041769549
755,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,51,Up,0.882477330128884,0.959572041769549
756,WP_CYTOSOLIC_DNASENSING_PATHWAY,55,Down,0.882526111408491,0.959572041769549
757,WP_IL2_SIGNALING,37,Up,0.884248195657165,0.960174394755865
758,WP_RETINOL_METABOLISM,6,Down,0.885534726269675,0.960260963499838
759,WP_THERMOGENESIS,75,Down,0.886664320311895,0.960260963499838
760,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.890062956893574,0.96212845275431
761,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,24,Up,0.890729625968406,0.96212845275431
762,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.891988299905095,0.962223599110221
763,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,34,Up,0.894218492021236,0.963365138193258
764,WP_COPPER_HOMEOSTASIS,40,Down,0.895946193181795,0.963963050779366
765,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Down,0.900884157047848,0.96800885894553
766,WP_CANCER_PATHWAYS,318,Down,0.90249134685186,0.96846982651727
767,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.904272421263594,0.969115945604529
768,WP_BREAST_CANCER_PATHWAY,91,Down,0.905937967619994,0.969385375407743
769,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,44,Down,0.906882425411867,0.969385375407743
770,WP_CYTOSINE_METHYLATION,7,Up,0.911420512394859,0.970468806115792
771,WP_HISTONE_MODIFICATIONS,37,Up,0.911706731499846,0.970468806115792
772,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Up,0.912077225339954,0.970468806115792
773,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Down,0.912618475824218,0.970468806115792
774,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.916317718376582,0.971224638987233
775,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,29,Up,0.916965449892739,0.971224638987233
776,WP_NEPHROTIC_SYNDROME,29,Up,0.917343137624794,0.971224638987233
777,WP_ID_SIGNALING,12,Down,0.918325956293177,0.971224638987233
778,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,59,Down,0.920055919105081,0.971224638987233
779,WP_ATR_SIGNALING,11,Down,0.921563308139761,0.971224638987233
780,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.922276392062302,0.971224638987233
781,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,11,Up,0.923725088028486,0.971224638987233
782,WP_VITAMIN_D_METABOLISM,6,Down,0.923963099377149,0.971224638987233
783,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Up,0.925434922824451,0.971529382581991
784,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,67,Up,0.928650642498828,0.972684151775951
785,WP_STEROID_BIOSYNTHESIS,2,Down,0.9298575714904,0.972684151775951
786,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,64,Down,0.931267729468064,0.972684151775951
787,WP_GPR40_PATHWAY,10,Up,0.931323337519315,0.972684151775951
788,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Up,0.932451473965267,0.972684151775951
789,WP_NOTCH_SIGNALING_WP61,49,Down,0.933664097605633,0.972714687239329
790,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,13,Up,0.936560091549103,0.973965898133842
791,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.937234824116629,0.973965898133842
792,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.939829819140269,0.975429433501643
793,WP_PI3KAKT_SIGNALING,181,Up,0.944091732066531,0.977397124096248
794,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.944117004902419,0.977397124096248
795,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.945292838998196,0.977397124096248
796,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.947752296932344,0.978245288532412
797,WP_CHOLESTEROL_METABOLISM,52,Down,0.951548057756541,0.978245288532412
798,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,44,Down,0.951872119373587,0.978245288532412
799,WP_G13_SIGNALING,30,Down,0.951905568488791,0.978245288532412
800,WP_CELLULAR_PROTEOSTASIS,6,Up,0.952668521203961,0.978245288532412
801,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,24,Up,0.954621333699057,0.978245288532412
802,WP_ACUTE_VIRAL_MYOCARDITIS,68,Down,0.955632094553161,0.978245288532412
803,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.958430193732324,0.978245288532412
804,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.958615082929912,0.978245288532412
805,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,14,Up,0.958874474912684,0.978245288532412
806,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,30,Up,0.959204017709397,0.978245288532412
807,WP_RETINOBLASTOMA_GENE_IN_CANCER,85,Down,0.963978584878823,0.981896402441626
808,WP_HEDGEHOG_SIGNALING_WP4249,25,Up,0.97064269938774,0.986999709938202
809,WP_BDNFTRKB_SIGNALING,27,Up,0.971390225474459,0.986999709938202
810,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,21,Down,0.972891149711364,0.98730435192931
811,WP_VALPROIC_ACID_PATHWAY,9,Up,0.978410916525893,0.991681594801829
812,WP_GLUCURONIDATION,7,Up,0.979876382313919,0.991943825445864
813,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,12,Up,0.983721132014552,0.993143533844528
814,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.983808094117073,0.993143533844528
815,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.984686107157288,0.993143533844528
816,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,76,Up,0.986954895949848,0.994211917243596
817,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,49,Up,0.988372526953516,0.99442131842814
818,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,44,Down,0.991587778486938,0.994830687733318
819,WP_IL6_SIGNALING,40,Up,0.991711856291905,0.994830687733318
820,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.992410175111096,0.994830687733318
821,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.997650119964739,0.998038602060025
822,WP_TCELL_ACTIVATION_SARSCOV2,63,Down,0.998038602060025,0.998038602060025
